Coffee prevents CCl4-induced liver cirrhosis in the rat

Hepatology International

Volumn 5, Issue 3, 2011, Pages 857-863

  Moreno, Mario G ^a   Chavez, Enrique ^a   Aldaba Muruato, Liseth R ^a   Segovia, Jose ^a   Vergara, Paula ^a   Tsutsumi, Vìctor ^a   Shibayama, Mineko ^a   Rivera Espinoza, Yadira ^b   Muriel, Pablo ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Antioxidants; Carbon tetrachloride; Cirrhosis; Coffee; Cytokines; Fibrosis; Liver damage; TGF

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; COLLAGEN; GLUTATHIONE; GLYCOGEN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; COFFEE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; ENZYME ACTIVITY; LIPID PEROXIDATION; LIVER CIRRHOSIS; LIVER HISTOLOGY; LIVER PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; THERAPY EFFECT; TRANSCRIPTION REGULATION;

EID: 80055014268     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-010-9247-6     Document Type: Article

References (36)

1. Caden ISH, Partovi N, Yoshida EM. Review article: possible beneficial effects of coffee on liver disease and function. Aliment Pharmacol Ther 2007;26:1-8
2. Spiller MA. The Chemical Components of Coffee. In Spiller GA, editor. Caffeine. Boca Raton: CRC Press; 1998. 97-161
3. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Rosner BA, Speizer FE, Hennekens CH. Coffee consumption and coronary heart disease in women. A ten-year follow up. JAMA 1996;275:458-462
4. Higdon JV, Frei B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 2006;46:101-123
5. Muriel P, Arauz J. Coffee and liver diseases. Fitoterapia 2010;81:297-305
6. Bergmeyer HU, Grabl M, Walter HE. Enzymes. In Bergmeyer J, Grabl M, editors. Methods of Enzymatic Analysis. Weinheim: Verlag-Chemie; 1983. 269-270
7. Reitman S, Frankel S. A colorimetric method for the determination of serum oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 1957;28:56-63
8. Seifter S, Dayton S, Novic B, Muntwyler E. The estimation of glycogen with the anthrone reagent. Arch Biochem 1950;25:191-200
9. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by the thiobarbituric acid reaction. Anal Biochem 1979;95:351-358 (Pubitemid 9194347)
10. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254
11. Hissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976;74:214-226
12. Prockop DJ, Udenfriend S. A specific method for the analysis of hydroxyproline in tissues and urine. Anal Biochem 1960;1:228-239
13. Pèrez-Severiano F, Escalante B, Vergara P, Rìos C, Segovia J. Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington's disease mutation. Brain Res 2002;951:36-42 (Pubitemid 35253894)
14. Garcia-Tovar CG, Perez A, Luna J, Mena R, Osorio B, Aleman V, Mondragon R, Mornet D, Rendòn A, Hernandez JM. Biochemical and histochemical analysis of 71 kDa dystrophin isoform (Dp71f) in rat brain. Acta Histochem 2001;103:209-224 (Pubitemid 32385679)
15. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci 2002;7:d793-d807
16. Wells RG, Fibrogenesis V. TGF-beta signaling pathways. Am J Physiol Gastrointest Liver Physiol 2000;279:G845-G850
17. Shi Y, Massaguè J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003;113:685-700 (Pubitemid 36724933)
18. Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, Tanjore H, Kalluri R. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007;282:23337-23347 (Pubitemid 47311952)
19. Weng HL, Ciuclan L, Liu Y, Hamzavi J, Godoy P, Gaitantzi H, Kanzler S, Heuchel R, Ueberham U, Gebhardt R, Breitkopf K, Dooley S. Profibrogenic transforming growth factor-beta/activinreceptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes. Hepatology 2007;46:1257-1270 (Pubitemid 350144790)
20. Gressner OA, Lahme B, Siluschek M, Rehbein K, Weiskirchen R, Gressner AM. Activation of TGF-beta within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor. J Cell Mol Med 2008;12:2717-2730
21. Gressner OA, Lahme B, Demirci I, Gressner AM, Weiskirchen R. Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes. J Hepatol 2007;47:699-710 (Pubitemid 47503426)
22. Leask A, Abraham DJ. All in the CCN family; essential matricellular signaling modulators emerge from the bunker. J Cell Sci 2006;119:4803-4810 (Pubitemid 46017793)
23. Hayashi N, Kakimuma T, Soma Y, Grotendorst GR, Tamaki K, Harada M, Igarashi A. Connective tissue growth factor is directly related to liver fibrosis. Hepatogastroenterology 2002;49:133-135 (Pubitemid 34289501)
24. Rachfal AW, Brigstock DR. Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res 2003;26:1-9 (Pubitemid 36939924)
25. Paradis V, Dargere D, Vidaud M, De Gouville AC, Huet S, Martinez V, Gauthier JM, Ba N, Sobesky R, Ratziu V, Bedossa P. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 1999;30:968-976 (Pubitemid 29458286)
26. George J, Tsutsumi M. siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamineinduced hepatic fibrosis in rats. Gene Ther 2007;14:790-803 (Pubitemid 46706059)
27. Li G, Xie Q, Shi Y, Li D, Zhang M, Jiang S, Zhou H, Lu H, Jin Y. Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats. J Gene Med 2006;8:889-900 (Pubitemid 44097143)
28. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, Huang X, Grotendorst GR. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down regulation by cAMP. FASEB J 1999;13:1774-1786 (Pubitemid 29473339)
29. Belibi FA, Wallace DP, Yamaguchi T, Chistensen M, Reif G, Grantham JJ. The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2002;13:2723-2729 (Pubitemid 35216041)
30. Gressner OA, Lahme B, Rehbein K, Siluschek M, Weiskirchen R, Gressner AM. Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. J Hepatol 2008;49:758-767
31. Klatsky AL, Armstrong MA. Alcohol, smoking, coffee and cirrhosis. Am J Epidemiol 1992;136:1248-1257
32. Klatsky AL, Armstrong MA, Friedman GD. Coffee, tea, and mortality. Ann Epidemiol 1993;3:375-381 (Pubitemid 23195822)
33. Tverdaland A, Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol 2003;13:419-423 (Pubitemid 36870809)
34. Corrao G, Lepore AR, Torchio P, Valenti M, Galatola G, D'Amicis A, Aricò S, di Orio F. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial group for the study of chronic liver disease. Eur J Epidemiol 1994;10:657-664
35. Corrao G, Zambon A, Bagnardi V, D'amicis A, Klatsky A. Collaborative SIDECIR Group. Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol 2001;11:458-465
36. Gallus S, Tavani A, Negri E, La Vecchia C. Does coffee protect against liver cirrhosis? Ann Epidemiol 2002;12:202-205 (Pubitemid 34189722)